Multiple Sclerosis: Subtypes, Symptoms, Diagnosis and Treatments Document List
Updated/Revised Date: 2018-12-17
Author: Disabled World | Contact us
Although some of these documents from our Multiple Sclerosis category may have since been updated, re-written, replaced, or revised, they are sorted below by their original publish date. The most recent publications are listed at the top of the table with older articles being listed in descending order by the date they were created.
You can also receive our latest related publications by subscribing to our Multiple Sclerosis RSS feed.
List of Multiple Sclerosis Publications:
Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment.
Those with MS who feel stigmatized are more likely to have depression, having a support system of friends and family and a sense of autonomy may help reduce the harmful effects of stigma..
Research proposals will invite researchers to establish a Canadian cohort of people living with MS to study progression in the disease.
Multiple Sclerosis study brings us closer to understanding which older adults with MS may be at higher risk of getting worse.
Phase III CLARITY study data revealed significant reduction in brain atrophy in patients on short course of investigational Cladribine Tablets over two years.
Study finds the age at which symptoms of multiple sclerosis (MS) first start is strongly linked to latitude.
Stem cell treatment improves established disability in patients with progressive MS and shows there is hope future treatment is possible.
Summary of significant 2015 multiple sclerosis research progress and initiatives from The National Multiple Sclerosis Society.
New research could lead to the development of new types of drugs to treat Multiple Sclerosis (MS).
Follow-up of girls and women who received human papillomavirus (HPV) vaccination found no increased risk for these disorders.
Research scientists are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patients own cells.
Case discovered that her inability to walk and other MS symptoms were triggered by her dental mercury fillings.
Health Canada approved FAMPYRA on February 10, 2012 for the symptomatic improvement of walking in adult MS patients with walking disability.
Minimally invasive endovascular treatment for CCSVI may produce significant improvement in physical and mental quality of life in individuals with MS.
Diagnostic breakthrough in multiple sclerosis reveals cause may be bio-mechanical related to earlier trauma to the neck resulting in obstruction of cerebrospinal fluid flow.
Molecular mechanism could bring about the development of new treatments for Multiple Sclerosis (MS).
Endovascular therapy or angioplasty is the nonsurgical procedure of threading a thin tube into a vein or artery to open blocked or narrowed blood vessels.
There is epidemiological evidence that some herpes viruses may contribute to multiple sclerosis (MS) occurrence.
Viagra drastically reduces multiple sclerosis symptoms in animal models with the disease.
New class of highly selective compounds that effectively suppresses the severity of multiple sclerosis.
Predicting whether patients will suffer a faster onset of disability and counsel them to help ease anxiety.
Gilenya delayed progression of disability both for patients who were previously treated for their MS and for patients who had not received prior treatment.
Multiple sclerosis is a seriously disabling autoimmune disease that can lead to disturbance or loss of sensory function voluntary movement vision and bladder control.
People living with MS need more information to make the best choices for the benefit of their health.
Multiple sclerosis is a life altering disease that affects each person in a unique and different way.
Gilenya (fingolimod) is the first disease modifying oral therapy developed for the relapsing-remitting form of multiple sclerosis (MS).
Fumaric acid salts used against severe psoriasis may also have a favorable effect on Multiple Sclerosis as a result of their TH2 polarizing mechanisms.
Damage to a particular area of the brain and a consequent reduction in noradrenaline are associated with multiple sclerosis.
Histamine could be an important molecule to developing new treatments for multiple sclerosis (MS).
MS Progress was made toward finding ways to restore function and improving quality of life through exercise meditation rehabilitation and medications.
Damage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the central nervous system.
The complexity of the immune system and nervous system turn Neuroimmunology into one of the most exciting fields of modern biomedicine.
Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients.
Albuterol sulfate used to treat bronchospasm in asthma may decrease interleukin-12 levels.
Meeting of leading North American experts in multiple sclerosis (MS) to identify research priorities for Canada.
Trial to test bone marrow stem cell therapy with patients with multiple sclerosis shown to have possible benefits for treatment of the disease.
Society of Interventional Radiology would like to be actively involved in developing evidence-based therapies for the potential treatment of patients with multiple sclerosis.
Hard To Treat Diseases (HTDS.PK) Scientists report results that are encouraging for the future of Multiple Sclerosis Treatment.
Join the Movement to End Multiple Sclerosis During MS Awareness Week March 8-14, 2010.
FDA approves Ampyra (dalfampridine) drug to improve walking in patients with multiple sclerosis (MS).
Major trial of oral drug Cladribine has shown it significantly reduces relapse and deterioration of multiple sclerosis (MS).
National Multiple Sclerosis Society continues to propel research forward to end MS.
People with multiple sclerosis who have relapses within five years of onset have more severe disability in the short term.
Research study could overturn the prevailing wisdom on the cause of multiple sclerosis (MS).
Study finds two genes associated with good central nervous system repair in multiple sclerosis.
Virus responsible for rare brain disease found to be reactivated in multiple-sclerosis patients being treated with natalizumab.
A new experimental treatment for multiple sclerosis (MS) completely reverses the devastating autoimmune disorder.
Antegren for multiple sclerosis is a monoclonal antibody that is given by monthly infusion into a vein.
The drug Naltrexone has stopped the progression of Multiple Sclerosis and enhanced the quality of life for Multiple Sclerosis sufferers.
Experimental drug fampridine 4-aminopyridine improves walking ability in some individuals with multiple sclerosis MS.
You're reading Disabled World. See our homepage for informative disability news, reviews, sports, stories and how-tos. You can also connect with us on social media such as Twitter and Facebook or learn more about Disabled World on our about us page.
Disclaimer: Disabled World provides general information only. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.
Cite This Page (APA): Disabled World. (2018, December 17). Multiple Sclerosis: Subtypes, Symptoms, Diagnosis and Treatments. Disabled World. Retrieved September 18, 2021 from www.disabled-world.com/health/autoimmunediseases/ms-2/